The authors reply.
Saved in:
| Title: | The authors reply. |
|---|---|
| Authors: | Wong K; Centre for Kidney and Bladder Health, University College London, UK; National Registry of Rare Kidney Diseases, Bristol, UK., Masoud S; Centre for Kidney and Bladder Health, University College London, UK; National Registry of Rare Kidney Diseases, Bristol, UK., Pitcher D; Centre for Kidney and Bladder Health, University College London, UK; National Registry of Rare Kidney Diseases, Bristol, UK., Downward L; National Registry of Rare Kidney Diseases, Bristol, UK., Proudfoot C; Health Economics and Outcomes Research (HEOR), Novartis Pharma AG, Basel, Switzerland., Webb NJA; Health Economics and Outcomes Research (HEOR), Novartis Pharma AG, Basel, Switzerland., Wong EKS; National Renal Complement Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Gale DP; Centre for Kidney and Bladder Health, University College London, UK; National Registry of Rare Kidney Diseases, Bristol, UK. Electronic address: d.gale@ucl.ac.uk. |
| Source: | Kidney international [Kidney Int] 2026 Jan; Vol. 109 (1), pp. 225-226. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print Cited Medium: Internet ISSN: 1523-1755 (Electronic) Linking ISSN: 00852538 NLM ISO Abbreviation: Kidney Int Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
